Free Trial

Burning Rock Biotech (BNR) Competitors

GBX 5.68
-1.47 (-20.56%)
(As of 07/8/2024)

BNR vs. OBI, OKYO, SBTX, AKR, TLY, AOR, RENX, VRCI, HEMO, and NSCI

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Ondine Biomedical (OBI), OKYO Pharma (OKYO), SkinBioTherapeutics (SBTX), Akers Biosciences (AKR), Totally (TLY), AorTech International (AOR), Renalytix (RENX), Verici Dx (VRCI), Hemogenyx Pharmaceuticals (HEMO), and NetScientific (NSCI). These companies are all part of the "medical" sector.

Burning Rock Biotech vs.

Ondine Biomedical (LON:OBI) and Burning Rock Biotech (LON:BNR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking.

Burning Rock Biotech received 64 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 69.89% of users gave Burning Rock Biotech an outperform vote.

CompanyUnderperformOutperform
Ondine BiomedicalOutperform Votes
1
100.00%
Underperform Votes
No Votes
Burning Rock BiotechOutperform Votes
65
69.89%
Underperform Votes
28
30.11%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ondine Biomedical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Burning Rock Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Burning Rock Biotech's average media sentiment score of 0.00 equaled Ondine Biomedical'saverage media sentiment score.

Company Overall Sentiment
Ondine Biomedical Neutral
Burning Rock Biotech Neutral

Burning Rock Biotech has lower revenue, but higher earnings than Ondine Biomedical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ondine Biomedical£856K26.44-£18.70M-£0.06-136.02
Burning Rock BiotechN/AN/AN/AN/AN/A

7.5% of Ondine Biomedical shares are owned by institutional investors. 50.0% of Ondine Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Ondine Biomedical's return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Ondine BiomedicalN/A -144.07% -70.25%
Burning Rock Biotech N/A N/A N/A

Summary

Ondine Biomedical beats Burning Rock Biotech on 4 of the 7 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechDiagnostic Imaging Centers IndustryMedical SectorLON Exchange
Market Cap£6.01M£6.01M£5.29B£1.43B
Dividend YieldN/AN/A2.80%11.87%
P/E RatioN/AN/A139.221,725.62
Price / SalesN/AN/A2,039.15303,983.04
Price / CashN/AN/A35.2832.75
Price / BookN/AN/A4.952.82
Net IncomeN/AN/A£111.27M£166.66M
7 Day PerformanceN/AN/A2.53%0.29%
1 Month Performance-20.56%-20.56%11.19%2.10%
1 Year Performance171.51%171.51%9.60%84.32%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OBI
Ondine Biomedical
0 of 5 stars
0.00 / 5 stars
GBX 8.65
+4.8%
N/A-45.2%£23.99M£856,000.00-144.17N/AGap Down
OKYO
OKYO Pharma
0 of 5 stars
0.00 / 5 stars
GBX 1.40
-24.3%
N/A+0.0%£23.24MN/A-140.007Gap Down
SBTX
SkinBioTherapeutics
0 of 5 stars
0.00 / 5 stars
GBX 11.55
+26.9%
N/A-5.8%£23.14M£21,949.00-577.5011Gap Up
High Trading Volume
AKR
Akers Biosciences
0 of 5 stars
0.00 / 5 stars
GBX 57.50
flat
N/A+0.0%£21.64M£2.32M-0.44120
TLY
Totally
2.1077 of 5 stars
2.11 / 5 stars
GBX 10.63
+2.4%
N/A-30.3%£20.88M£121.20M-515.001,668Analyst Forecast
News Coverage
Gap Up
High Trading Volume
AOR
AorTech International
0 of 5 stars
0.00 / 5 stars
GBX 123.50
-2.4%
N/AN/A£19.99M£539,000.00-33.383
RENX
Renalytix
0 of 5 stars
0.00 / 5 stars
GBX 13.48
+3.7%
N/A-89.1%£19.88M£2.41M-44.92102Gap Up
VRCI
Verici Dx
0 of 5 stars
0.00 / 5 stars
GBX 7.17
-4.5%
N/A-39.1%£17.38MN/A-143.3014Gap Up
HEMO
Hemogenyx Pharmaceuticals
0 of 5 stars
0.00 / 5 stars
GBX 1.30
-2.6%
N/A-12.9%£17.37MN/A-129.6014Gap Down
NSCI
NetScientific
0 of 5 stars
0.00 / 5 stars
GBX 72
+1.4%
N/A+24.6%£17.24M£1.38M-553.8526News Coverage

Related Companies and Tools

This page (LON:BNR) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners